Lorrain Daniel S.'s Form 4 filing
Contineum Therapeutics, Inc. (CTNM) · filed Nov 27, 2024
- Accession no.
- 0001437749-24-036349
- Filed
- Nov 27, 2024
- Trade date
- Nov 25, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $16.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lorrain Daniel S.CIK 0001861550 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2024 | Class A Common Stock | SSaleDisposed | −1,010 | $16.02 | −$16,180.2 | 168,562 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.